METHOD FOR TREATING STEATOHEPATITIS

METHOD FOR TREATING STEATOHEPATITIS

FIELD: medicine, hepatology. ^ SUBSTANCE: at achieving alkaline phosphatase of 580 U and more one should introduce ursodesoxycholic acid at the dosage of 15-20 mg/kg and orlistate at the dosage of 90-100 mg twice or thrice daily for patients with steatohepatitis. According to normalization of clinic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MEL'NIKOVA N.V, LAZEBNIK L.B, LYCHKOVA A.EH, ZVENIGORODSKAJA L.A, OVSJANNIKOVA O.N
Format: Patent
Sprache:eng ; rus
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MEL'NIKOVA N.V
LAZEBNIK L.B
LYCHKOVA A.EH
ZVENIGORODSKAJA L.A
OVSJANNIKOVA O.N
description FIELD: medicine, hepatology. ^ SUBSTANCE: at achieving alkaline phosphatase of 580 U and more one should introduce ursodesoxycholic acid at the dosage of 15-20 mg/kg and orlistate at the dosage of 90-100 mg twice or thrice daily for patients with steatohepatitis. According to normalization of clinical and biochemical values of blood analyses it is possible to conclude upon successfulness of therapy performed. The method provides clinic-laboratory remission of the disease. ^ EFFECT: higher efficiency of therapy. ^ 3 ex
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2248793C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2248793C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2248793C13</originalsourceid><addsrcrecordid>eNrjZFD2dQ3x8HdRcPMPUggJcnUM8fRzVwgOATL8PVwDgNwQz2AeBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhIfFGpkZGJhbmnsbGhMhBIAMTAiwQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR TREATING STEATOHEPATITIS</title><source>esp@cenet</source><creator>MEL'NIKOVA N.V ; LAZEBNIK L.B ; LYCHKOVA A.EH ; ZVENIGORODSKAJA L.A ; OVSJANNIKOVA O.N</creator><creatorcontrib>MEL'NIKOVA N.V ; LAZEBNIK L.B ; LYCHKOVA A.EH ; ZVENIGORODSKAJA L.A ; OVSJANNIKOVA O.N</creatorcontrib><description>FIELD: medicine, hepatology. ^ SUBSTANCE: at achieving alkaline phosphatase of 580 U and more one should introduce ursodesoxycholic acid at the dosage of 15-20 mg/kg and orlistate at the dosage of 90-100 mg twice or thrice daily for patients with steatohepatitis. According to normalization of clinical and biochemical values of blood analyses it is possible to conclude upon successfulness of therapy performed. The method provides clinic-laboratory remission of the disease. ^ EFFECT: higher efficiency of therapy. ^ 3 ex</description><edition>7</edition><language>eng ; rus</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20050327&amp;DB=EPODOC&amp;CC=RU&amp;NR=2248793C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20050327&amp;DB=EPODOC&amp;CC=RU&amp;NR=2248793C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MEL'NIKOVA N.V</creatorcontrib><creatorcontrib>LAZEBNIK L.B</creatorcontrib><creatorcontrib>LYCHKOVA A.EH</creatorcontrib><creatorcontrib>ZVENIGORODSKAJA L.A</creatorcontrib><creatorcontrib>OVSJANNIKOVA O.N</creatorcontrib><title>METHOD FOR TREATING STEATOHEPATITIS</title><description>FIELD: medicine, hepatology. ^ SUBSTANCE: at achieving alkaline phosphatase of 580 U and more one should introduce ursodesoxycholic acid at the dosage of 15-20 mg/kg and orlistate at the dosage of 90-100 mg twice or thrice daily for patients with steatohepatitis. According to normalization of clinical and biochemical values of blood analyses it is possible to conclude upon successfulness of therapy performed. The method provides clinic-laboratory remission of the disease. ^ EFFECT: higher efficiency of therapy. ^ 3 ex</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFD2dQ3x8HdRcPMPUggJcnUM8fRzVwgOATL8PVwDgNwQz2AeBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhIfFGpkZGJhbmnsbGhMhBIAMTAiwQ</recordid><startdate>20050327</startdate><enddate>20050327</enddate><creator>MEL'NIKOVA N.V</creator><creator>LAZEBNIK L.B</creator><creator>LYCHKOVA A.EH</creator><creator>ZVENIGORODSKAJA L.A</creator><creator>OVSJANNIKOVA O.N</creator><scope>EVB</scope></search><sort><creationdate>20050327</creationdate><title>METHOD FOR TREATING STEATOHEPATITIS</title><author>MEL'NIKOVA N.V ; LAZEBNIK L.B ; LYCHKOVA A.EH ; ZVENIGORODSKAJA L.A ; OVSJANNIKOVA O.N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2248793C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2005</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MEL'NIKOVA N.V</creatorcontrib><creatorcontrib>LAZEBNIK L.B</creatorcontrib><creatorcontrib>LYCHKOVA A.EH</creatorcontrib><creatorcontrib>ZVENIGORODSKAJA L.A</creatorcontrib><creatorcontrib>OVSJANNIKOVA O.N</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MEL'NIKOVA N.V</au><au>LAZEBNIK L.B</au><au>LYCHKOVA A.EH</au><au>ZVENIGORODSKAJA L.A</au><au>OVSJANNIKOVA O.N</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR TREATING STEATOHEPATITIS</title><date>2005-03-27</date><risdate>2005</risdate><abstract>FIELD: medicine, hepatology. ^ SUBSTANCE: at achieving alkaline phosphatase of 580 U and more one should introduce ursodesoxycholic acid at the dosage of 15-20 mg/kg and orlistate at the dosage of 90-100 mg twice or thrice daily for patients with steatohepatitis. According to normalization of clinical and biochemical values of blood analyses it is possible to conclude upon successfulness of therapy performed. The method provides clinic-laboratory remission of the disease. ^ EFFECT: higher efficiency of therapy. ^ 3 ex</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2248793C1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title METHOD FOR TREATING STEATOHEPATITIS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T04%3A18%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MEL'NIKOVA%20N.V&rft.date=2005-03-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2248793C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true